Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001–2010

[1] Compston A(2002)Multiple sclerosis Lancet 359 1221-1231

[2] Coles A(2003)Incidence and prevalence of multiple sclerosis in Olmsted Country, Minnesota, 1985–2000 Neurology 61 1373-1377

[3] Mayr WT(2005)Multiple sclerosis: diagnosis and the management of acute relapses Postgrad Med J 81 302-308

[4] Pittock SJ(1998)Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability Neurology 50 701-708

[5] McClelland RL(1996)Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis Ann Neurol 39 285-294

[6] Jorgenson NW(1998)Randomised double-blind placebo-controlled study of interferon ß-1a in relapsing/remitting multiple sclerosis Lancet 352 1498-1504

[7] Noseworthy JH(1993)Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 43 655-661

[8] Rodriguez M(2006)A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 354 899-910

[9] Leary SM(2010)A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 387-401

[10] Porter B(2011)Randomized trial of oral teriflunomide for relapsing multiple sclerosis N Engl J Med 365 1293-1303

[1] Compston A(2002)Multiple sclerosis Lancet 359 1221-1231

[2] Coles A(2003)Incidence and prevalence of multiple sclerosis in Olmsted Country, Minnesota, 1985–2000 Neurology 61 1373-1377

[3] Mayr WT(2005)Multiple sclerosis: diagnosis and the management of acute relapses Postgrad Med J 81 302-308

[4] Pittock SJ(1998)Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability Neurology 50 701-708

[5] McClelland RL(1996)Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis Ann Neurol 39 285-294

[6] Jorgenson NW(1998)Randomised double-blind placebo-controlled study of interferon ß-1a in relapsing/remitting multiple sclerosis Lancet 352 1498-1504

[7] Noseworthy JH(1993)Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 43 655-661

[8] Rodriguez M(2006)A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 354 899-910

[9] Leary SM(2010)A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 387-401

[10] Porter B(2011)Randomized trial of oral teriflunomide for relapsing multiple sclerosis N Engl J Med 365 1293-1303